Risk factor
Very high price volatility
Profitability factor
Favourable analyst view
About
ABL Bio Inc. is a biotechnology research company based in Seongnam, South Korea. The firm is dedicated to advancing therapeutic medications, primarily concentrating its efforts on treatments for immuno-oncology and neurodegenerative conditions. Its current lineup of investigational drugs features ABL001, various cancer immunotherapies, ADCs, and ABL301.
Company Valuation
Considering past and projected metrics, the stock is distinctly 'expensive' compared to its peers. In particular, the stock is overvalued on P/FCF.
Target Price
The average target price of 298380.KQ is 233443 and suggests 139% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation t